Clinical trials: ASCVD

Hypercholesterolemia; ASCVD; Pregnancy

Evolocumab Pregnancy Exposure Registry

• Terminated
• Age: 1 year to 100 years
• Observational study

This is a prospective observational registry study to evaluate fetal, infant and childhood outcomes in women exposed to evolocumab during pregnancy

Trial name

NCT02957604

Testing

evolocumab

Volunteers

140 people

Sponsor

Amgen